ICU Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $376K

  • Investors
  • 6

ICU General Information

Description

Manufacturer of advanced optical imaging devices intended to enhance diagnostic capabilities in ophthalmology. The company offers features such as high-resolution imaging technology, real-time analysis of tear film dynamics, and comprehensive data reporting, enabling healthcare professionals to improve patient outcomes in the management of ocular conditions while facilitating research and clinical applications in eye care.

Contact Information

Website
www.icuvc.kr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1Floor, 259 Myeongji Gukje 8-ro
  • Gangseo-gu
  • Busan
  • South Korea
+82
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Corporate Office
  • 1Floor, 259 Myeongji Gukje 8-ro
  • Gangseo-gu
  • Busan
  • South Korea
+82

ICU Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ICU Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 01-Oct-2024 $376K Completed Clinical Trials - Phase 1
3. Accelerator/Incubator 18-Sep-2024 Completed Clinical Trials - Phase 1
2. Accelerator/Incubator 16-Jul-2024 $313K Completed Clinical Trials - Phase 1
1. Seed Round 01-Oct-2023 $313K $313K Completed Pre-Clinical Trials
To view ICU’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ICU Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ICU Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
NVC Partners Venture Capital Minority
Series Ventures Venture Capital Minority
Tech Incubator Program for Startup Accelerator/Incubator
IBK Changgong Accelerator/Incubator
AI Angel Club Angel Group Minority
You’re viewing 5 of 6 investors. Get the full list »

ICU FAQs

  • When was ICU founded?

    ICU was founded in 2022.

  • Where is ICU headquartered?

    ICU is headquartered in Busan, South Korea.

  • What is the size of ICU?

    ICU has 5 total employees.

  • What industry is ICU in?

    ICU’s primary industry is Therapeutic Devices.

  • Is ICU a private or public company?

    ICU is a Private company.

  • What is ICU’s current revenue?

    The current revenue for ICU is .

  • How much funding has ICU raised over time?

    ICU has raised $688K.

  • Who are ICU’s investors?

    NVC Partners, Series Ventures, Tech Incubator Program for Startup, IBK Changgong, and AI Angel Club are 5 of 6 investors who have invested in ICU.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process